Histochemical study of the nitric oxide synthase activity in experimental trichinellosis

• Autorzy: Hadas E , Gustowska L. , Boczon K. , Janczewska D.
• Języki publikacji: EN

Abstrakty

EN

Nitric oxide plays a critical role in a variety of biological acfivities. It has been nicknamed a ,,killer'' and ,,mediator" due to its toxic and signalling properties. Apart from its regular physiological function, nitric oxide indirectly participates in infectious diseases. Our report seems to be first presentation of the nitric oxide synthase participation in the host biochemical defence mechanisms and in morphological transformation of muscle cells in trichinellosis.

Słowa kluczowe

EN

toxic property; trichinellosis; nitric oxide; morphological transformation; parasitology; muscle cell; signalling property; infectious disease; physiological function; synthase activity; histochemistry

• Wydawca: -
• Czasopismo: Wiadomości Parazytologiczne
• Rocznik: 1999
• Tom: 45
• Numer: 1
• Opis fizyczny: p.63-68,fig.,ref.

Twórcy

autor

Hadas E

• University of Medical Sciences, Poznan, Poland

autor

Gustowska L.

autor

Boczon K.

autor

Janczewska D.

Bibliografia

• ADAMS L. B., HIBBS J. B. Jr . TAINTOR R, KRAHENBUHL J . L. 1990. Miaobiostatic effect of murine macrophages for Toxoplasma gondii: role of synthesis of inorganic nitrogen oxides from. L- arginine. J. Imnnmol. 144: 2725-2729.
• BILIJAR. T. R., CURRAN R. D., STUEHR D. J., STADLER J., SIMMONS R. L., MURRAY S. A 1990. Inducible cytosolic eozyme activity for the puduction of nitrogen oxides from L-arginine in hepatocytes. Bioch. Biophys. Res. Com. 168: 1034-1040.
• BEESLEY J. 1995. Histochemical methods for defecting nitric oxide synthase. Histochem. J. 27: 757-769.
• BISSONNETTE E. Y., HOGABOAM C. M, WALLACE J. L., BUIUS A D. 1991. Potentiation of tumour necrosis factor-a-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147: 3060-3065.
• GABRYEL P., GUSTOWSKA L., BŁOTNA-FILIPIAK M 1995. The unique and specific transformation of muscle cell infected with T. spiralis. BAM 5: 231-238.
• GRIFFITH O. W., STUEHR D. J. 1995. Nitric oxide synthases: properties and catalytic mechanism. Ann. Rev. Physiol. 57: 707-736.
• GROSS S. S., WOLIN M. S. 1995. Nitric oxide: pathophysiological mechanisms. Mn. Rev. Physiol. 57: 737-769.
• HADAŚ E., GUSTOWSKA L. 1995. Histochemical investigations of the biochemical defence mechanism in experimental trichinellosis. I. Peroxidase acdvity. Trop. Med. Parasitol. 46: 278-280.
• HADAŚ E., GUSTOWSKA L., JANCZEWSKA D. 1995. Histochemical investigations of the biochemical defence mechanism in experimental trichinellosis. II. Prostaglandin synthase activity. Trop. Med. Parasitol. 46: 278-280.
• HADAŚ E., GUSTOWSKA L., DERDA M (in preparation). Histochemical investigations of the biochemical defence mechanism in experimental trichinellosis. IV. Superoxide dismutase activity.
• HIBBS J. B., TAINTOR R. R., VAVARIN Z., RACHLIN E. M 1988. Nitric oxide: a cytotoxic activated macrophage etfector molecule. Biochem. Biophys. Res. Com. 157: 87-94.
• HUTCHINSON P. J. A, PALMER R. M, MONCADA S. 1987. Comparative pharmacology of EDRF and nitric oxide on vascular strips. Europ. J. Pharmacol. 141: 445-451.
• KNOWLES R. G., MERRETT M, SALTER N., MONCADA S. 1990. Ditferential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat Biochem. J. 270: 833-836.
• KNOWLES R. G., MONCADA S. 1992. Nitric oxide as a signal in blood vessels. Trend, in Biochem. Sci. 17: 399-402.
• LIEW F. Y. 1993. The role of nitric oxide in parasitic diseases. Ann. Trop. Med. Parasitol. 87: 637-642.
• MARLETTA M. A, YOONP. S., IYENGAR R., LEAFC. D., WISHNOK J. S. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochem. 27: 8706-8711.
• MCCALL. T. B., BOUGHTON-SMITH N. K., PALMER R. M J., WHITTLE B. J. R., MONCADA S. 1989. Synthesis of nitric oxide from L-arginine by neutropbils. Release and interaction with superoxide anion. Biochem. J. 261: 293-296.
• NORRIS P. J., CHARLES I. G., SCORER C. A, EMSoN P. C. 1995. Studies on the localisation and expression of nitric oxide synthase using histochemical technique. Histochem. J. 27: 745-756.
• RIMELE T. J.,STURMM R. J., ADAMS L. M., HENRY D. E., HEASLIP R. J., WEICHMAN B. M, GRIMES D. 1988. Interaction of neutrophils with vascular smooth muscle: identifcation of a neutrophil-derived relaxing factor. J. Phannacol. Exp. Therapy 245: 102-111.
• SALVEMINI D., DE NUCCI G., GRYGLEWSKI R. J., VANE J. R. 1989. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc. Nat. Acad. Sc. U. S. A. 86: 6328-6332.
• SALVEMINI D., MASINI E., ANGGARD E., MANNAIONI P. F., VANE J. 1990. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition óf platelet aggregation. Biochem. Biophys. Ąes. Comm. 169: 596-601.
• SCHMIDT H. H. H., SEIFERT R., BOHME E. 1989. Formation and release of nitric oxide from human neutrophil and HL-60 cells induced by chemotactic peptide, platelet activating factur and leukotriene B4. FEBS Letters 244: 357-360.
• STUEHR. D. J., GROSS S., SAKUMA I., LEVI R., NATHAN C. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitricoxide. J. Exp. Med. 169: 1011-1020.
• STUEHR D. J., MARLETTA M. A 1987. Synthesis of nitrite and nitrate in murine macrophage cell line. Cancer Res. 47: 5590-5594.
• WHITE K. A, MARLETTA M. A 1992. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochem. 31: 6627-6631.
• WHITTLE B. J. R 1995. Nitric oxide in physiology and pathology. Histochem. J. 27: 727-737.
• WRIGHT, C. E., MULSCH A, BUSSE R., OSSWALD H. 1989. Generation of nitric oxide by human neutrophils. Biochem. Biophys. Ąes. Comm. 160: 813-819.